+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment, By Gender, By Sales Channel, By End-use, By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 120 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 4764586
Description Jump to:

Quick Summary:

In an era defined by transformation and evolution, the opportunity to monitor and understand industry trends has never been more vital. The global alopecia market encompasses a sphere ripe for analysis, and with our expertly curated market research report, you'll be well equipped to navigate the shifting dynamics of this growing field. Our comprehensive market report dives deep into the key elements that influence and shape the alopecia market, providing critical resources for discerning business executives.

Factors driving the market growth include the prevalent rise of alopecia conditions globally, the introduction of targeted pharmaceutical treatments, and the overall increase in global awareness about the disease and its potential treatments. However, the market also faces challenges, such as limited drug availability and the high cost of new treatments. This report highlights insights around the prominence of different types of alopecia treatments, underlying classifications, regional growth dynamics, and major market participants. Our aim is to support you in making informed business decisions and to anticipate emerging trends in the alopecia industry.

The global alopecia market size is expected to reach USD 16.02 billion by 2030, according to this report. The market is expected to expand at a CAGR of 9.0% from 2023 to 2030. The approval of JAK inhibitors and tyrosine kinase inhibitors along with the rising target disease prevalence is expected to drive market growth.

The prevalence of alopecia areata (AA) and alopecia totalis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.

The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly’s Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer’s Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.

Another key factor driving the industry’s growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.

The limited availability of targeted drugs that treat the underlying condition is one key challenge for the market. While new products with targeted mechanisms of action are being approved the high cost of these drugs in comparison to the already approved products is one of the major hindrances in their widespread adoption.

Alopecia Market Report Highlights

  • In 2022, the AA segment dominated the alopecia industry with a revenue share of 35.13% and is anticipated to maintain its pole position throughout the forecast period
  • The alopecia universalis segment is expected to witness the fastest growth from 2023 to 2030, owing to the impending approval of pipeline products, such as Pfizer’s Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics’s BNZ-1 which is in phase 2 clinical trials
  • North America dominated the market in 2022, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
  • Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease
  • A few of the key market players include Janssen Global Services Inc.; Cipla Limited; Merck & Co., Inc.; GlaxoSmithKline plc; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Aurobindo Pharma; Viatris Inc.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Alopecia Market

What is the estimated value of the Global Alopecia Market?

The Global Alopecia Market was estimated to be valued at $8.2 Billion in 2022.

What is the growth rate of the Global Alopecia Market?

The growth rate of the Global Alopecia Market is 9.0%, with an estimated value of $16.02 Billion by 2030.

What is the forecasted size of the Global Alopecia Market?

The Global Alopecia Market is estimated to be worth $16.02 Billion by 2030.

Who are the key companies in the Global Alopecia Market?

Key companies in the Global Alopecia Market include Janssen Global Services Inc., Cipla Limited, Merck & Co., Inc., GlaxoSmithKline plc, Sun Pharmaceuticals Industries Ltd, Dr. Reddy’s Laboratories Ltd, Aurobindo Pharma, Viatris Inc., Pfizer, Inc. and Lilly.
Report AttributeDetails
No. of Pages120
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 8.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.02 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned17

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.1.4 Segment Definitions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot 1
2.3. Segment Snapshot 2
2.4. Competitive Landscape Snapshot
Chapter 3 Alopecia Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing global prevalence of alopecia
3.3.1.2 Increasing global healthcare expenditure
3.3.1.3 Increasing prevalence of chronic diseases
3.3.1.3.1 PCOS
3.3.1.3.2 Cancer
3.3.1.3.3 Rheumatoid Arthritis
3.3.1.4 Technological advancements in alopecia treatment
3.3.2 Market restraint analysis
3.3.2.1 Lack of reimbursement policies for alopecia treatment
3.3.2.2 Increasing adoption of substitutes
3.4 Alopecia: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Pipeline Analysis
Chapter 4 Alopecia Market: Disease Type Estimates & Trend Analysis
4.1 Type Movement Analysis & Market Share, 2022 & 2030
4.2 Alopecia Market Estimates & Forecast, By Type (USD Million)
4.2.1 Alopecia Areata
4.2.1.1 Global Alopecia areata market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.1.2 Male alopecia areata market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.1.3 Female alopecia areata market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2 Cicatricial Alopecia
4.2.2.1 Global Cicatricial alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2.2 Male cicatricial alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2.3 Female cicatricial alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3 Traction Alopecia
4.2.3.1 Global Traction alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3.2 Male traction alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3.3 Female traction alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.4 Alopecia Totalis
4.2.4.1 Global Alopecia totalis market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.4.2 Male alopecia totalis market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.4.3 Female alopecia totalis market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5 Alopecia Universalis
4.2.5.1 Global Alopecia universalis market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.2 Male alopecia universalis market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.3 Female alopecia universalis market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.6 Androgenetic Alopecia
4.2.6.1 Global Androgenetic alopecia market, 2018 - 2030 (USD Million)
4.2.6.2 Male androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.6.3 Female androgenetic alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.7 Others
4.2.7.1 Global Other alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.7.2 Male other alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.7.3 Female other alopecia market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Alopecia Market: Treatment Estimates & Trend Analysis
5.1 Treatment Movement Analysis & Market Share, 2022 & 2030
5.2 Alopecia Market: Estimates & Forecast, By Treatment (USD, Million)
5.2.1 Pharmaceuticals
5.2.1.1 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2 Topical market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.1 OTC market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.1.1 Minoxidil market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.1.2 Others market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.1.2 Prescription market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.1.2.1 Betamethasone Dipropionate market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.1.2.2 Fluocinolone Acetonide market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.1.2.3 Finasteride market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.1.2.4 Minoxidil market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2 Oral market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.1 OTC market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.2 Prescription market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.2.1 Corticosteroids market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.2.2 Finasteride market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.2.3 Minoxidil market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.2.2.4 Others (JAK inhibitors and others) market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.1.3 PRP market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2 Devices
5.2.2.1 Devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2.2 Laser Cap market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2.3 Laser Comb market estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2.4 Laser Helmet market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 Alopecia Market: Segment Analysis, By Gender, 2018 - 2030 (USD Million)
6.1 Gender Movement Analysis & Market Share, 2022 & 2030
6.2 Alopecia Market: Estimates & Forecast, By Gender (USD, Million)
6.2.1 Male
6.2.1.6 Male market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.2 Female
6.2.2.1 Female market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7 Alopecia Market: Segment Analysis, By Sales Channel, 2018 - 2030 (USD Million)
7.1 Sales Channel Movement Analysis & Market Share, 2022 & 2030
7.2 Alopecia Market: Estimates & Forecast, By Sales Channel (USD, Million)
7.2.1 Prescriptions
7.2.1.6 Prescriptions market estimates and forecasts, 2018 - 2030 (USD Million)
7.2.2 OTC
7.2.2.1 OTC market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Alopecia Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)
8.1 End-use Movement Analysis & Market Share, 2022 & 2030
8.2 Alopecia Market: Estimates & Forecast, By End-use (USD, Million)
8.2.1 Homecare Settings
8.2.1.6 Homecare market estimates and forecasts, 2018 - 2030 (USD Million)
8.2.2 Dermatology Clinics
8.2.2.1 Dermatology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9 Alopecia Market: Regional Estimates and Trend Analysis
9.1 Alopecia Market: Regional Outlook
9.2 North America
9.2.1 North America Alopecia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 U.S. Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.2.2.3 Target Disease Prevalence
9.2.2.4 Competitive Scenario
9.2.2.5 Regulatory Framework
9.2.2.7 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Canada Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.2.3.3 Target Disease Prevalence
9.2.3.4 Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Alopecia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2 U.K.
9.3.2.1 Key Country Dynamics
9.3.2.2 U.K. Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.2.3 Target Disease Prevalence
9.3.2.4 Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Germany Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.3.3 Target Disease Prevalence
9.3.3.4 Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 France Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.4.3 Target Disease Prevalence
9.3.4.4 Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Italy
9.3.5.1 Key Country Dynamics
9.3.5.2 Italy Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.5.3 Target Disease Prevalence
9.3.5.4 Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Spain
9.3.6.1 Key Country Dynamics
9.3.6.2 Spain Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.6.3 Target Disease Prevalence
9.3.6.4 Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.9.1 Key Country Dynamics
9.3.9.2 Denmark Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Sweden Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.8.3 Target Disease Prevalence
9.3.8.4 Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Norway Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.4 Asia Pacific
9.4.1 Asia Pacific Alopecia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Japan Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.4.2.3 Target Disease Prevalence
9.4.2.4 Competitive Scenario
9.4.2.5 Regulatory Framework
9.4.2.6 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 China Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.4.3.3 Target Disease Prevalence
9.4.3.4 Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 india
9.4.4.1 Key Country Dynamics
9.4.4.2 India Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.4.4.3 Target Disease Prevalence
9.4.4.4 Competitive Scenario
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 Australia
9.4.5.1 Key Country Dynamics
9.4.5.2 Australia Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.4.5.3 Target Disease Prevalence
9.4.5.4 Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 South Korea
9.4.6.1 Key Country Dynamics
9.4.6.2 South Korea Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.4.6.3 Target Disease Prevalence
9.4.6.4 Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 Thailand
9.4.9.1 Key Country Dynamics
9.4.9.2 Thailand Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.4.9.3 Target Disease Prevalence
9.4.9.4 Competitive Scenario
9.4.9.5 Regulatory Framework
9.4.9.6 Reimbursement Scenario
9.5 Latin America
9.5.1 Latin America Alopecia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Mexico Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.5.3.3 Target Disease Prevalence
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Argentina Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.5.4.3 Target Disease Prevalence
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.6 Middle East and Africa
9.6.1 Middle East and Africa Alopecia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.1.1 Target Disease Prevalence
9.6.1.2 Competitive Scenario
9.6.1.3 Regulatory Framework
9.6.1.4 Reimbursement Scenario
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 South Africa Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.6.2.3 Target Disease Prevalence
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Saudi Arabia Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.6.3.3 Target Disease Prevalence
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 UAE Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.6.4.3 Target Disease Prevalence
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 KUWAIT
9.6.5.1 Key Country Dynamics
9.6.5.2 Kuwait Alopecia Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
9.6.5.3 Target Disease Prevalence
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
Chapter 10 Alopecia Market: Competitive Landscape
10.1 Company Categorization
10.1.1 Janssen Global Services Inc.
10.1.1.1 Overview
10.1.1.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.1.3 Product Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Cipla Limited
10.1.2.1 Overview
10.1.2.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Merck & Co., Inc.
10.1.3.1 Overview
10.1.3.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.3.3 Product Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 GlaxoSmithKline plc
10.1.4.1 Overview
10.1.4.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Sun Pharmaceuticals Industries Ltd
10.1.5.1 Overview
10.1.5.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 Dr. Reddy’s Laboratories Ltd
10.1.6.1 Overview
10.1.6.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 Aurobindo Pharma
10.1.7.1 Overview
10.1.7.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.7.3 Product Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 Viatris Inc.
10.1.8.1 Overview
10.1.8.2 Product Benchmarking
10.1.8.3 Strategic Initiatives
10.1.9 Pfizer, Inc.
10.1.9.1 Overview
10.1.9.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.9.3 Product Benchmarking
10.1.9.4 Strategic Initiatives
10.1.10 Lilly
10.1.10.1 Overview
10.1.10.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.10.3 Product Benchmarking
10.1.10.4 Strategic Initiatives
10.1.11 Lexington Intl., LLC (Devices)
10.1.11.1 Overview
10.1.11.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.11.3 Product Benchmarking
10.1.11.4 Strategic Initiatives
10.1.12 Freedom Laser Therapy (iRestore ID-520 helmet)
10.1.12.1 Overview
10.1.12.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.12.3 Product Benchmarking
10.1.12.4 Strategic Initiatives
10.1.13 Curallux, LLC.
10.1.13.1 Overview
10.1.13.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.13.3 Product Benchmarking
10.1.13.4 Strategic Initiatives
10.1.14 Apira Science Inc. (iGROW Laser)
10.1.14.1 Overview
10.1.14.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.14.3 Product Benchmarking
10.1.14.4 Strategic Initiatives
10.1.15 Revian Inc.
10.1.15.1 Overview
10.1.15.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.15.3 Product Benchmarking
10.1.15.4 Strategic Initiatives
10.1.16 Theradome
10.1.16.1 Overview
10.1.16.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.16.3 Product Benchmarking
10.1.16.4 Strategic Initiatives
10.1.17 Lutronic
10.1.17.1 Overview
10.1.17.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.1.17.3 Product Benchmarking
10.1.17.4 Strategic Initiatives
10.2 Participant’s Overview
10.3 Financial Performance
10.4 Product Benchmarking
10.5 Company Market Share Analysis, 2022
10.6 Strategy Mapping
10.6.1 Strategy Mapping
10.6.2. Expansion
10.6.2. Acquisition
10.6.3. Product/Service Launch
10.6.4. Others
Chapter 11. Analyst View
List of Tables
1. List of secondary sources
2. List of abbreviations
3. Healthcare reimbursement in the last four years (% of GDP)
4. List of late-stage clinical trials
5. List of parameters
6. Leading market players are anticipated to witness the highest growth
7. List of key distributors
8. Global Alopecia Market, By Region, 2018-2030 (USD Million)
9. Global Alopecia Market, By Treatment, 2018-2030 (USD Million)
10. Global Alopecia Market, By Disease Type, 2018-2030 (USD Million)
11. Global Alopecia Market, By Gender, 2018-2030 (USD Million)
12. Global Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
13. Global Alopecia Market, By End-use, 2018-2030 (USD Million)
14. North America Alopecia Market, By Country, 2018-2030 (USD Million)
15. North America Alopecia Market, By Treatment, 2018-2030 (USD Million)
16. North America Alopecia Market, By Disease Type, 2018-2030 (USD Million)
17. North America Alopecia Market, By Gender, 2018-2030 (USD Million)
18. North America Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
19. North America Alopecia Market, By End-use, 2018-2030 (USD Million)
20. 20 U.S. Alopecia Market, By Treatment, 2018-2030 (USD Million)
21. U.S. Alopecia Market, By Disease Type, 2018-2030 (USD Million)
22. U.S. Alopecia Market, By Gender, 2018-2030 (USD Million)
23. U.S. Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
24. U.S. Alopecia Market, By End-use, 2018-2030 (USD Million)
25. Canada Alopecia Market, By Treatment, 2018-2030 (USD Million)
26. Canada Alopecia Market, By Disease Type, 2018-2030 (USD Million)
27. Canada Alopecia Market, By Gender, 2018-2030 (USD Million)
28. Canada Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
29. Canada Alopecia Market, By End-use, 2018-2030 (USD Million)
30. Europe Alopecia Market, By Country, 2018-2030 (USD Million)
31. Europe Alopecia Market, By Treatment, 2018-2030 (USD Million)
32. Europe Alopecia Market, By Disease Type, 2018-2030 (USD Million)
33. Europe Alopecia Market, By Gender, 2018-2030 (USD Million)
34. Europe Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
35. Europe Alopecia Market, By End-use, 2018-2030 (USD Million)
36. UK Alopecia Market, By Treatment, 2018-2030 (USD Million)
37. UK Alopecia Market, By Disease Type, 2018-2030 (USD Million)
38. UK Alopecia Market, By Gender, 2018-2030 (USD Million)
39. UK Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
40. UK Alopecia Market, By End-use, 2018-2030 (USD Million)
41. Germany Alopecia Market, By Treatment, 2018-2030 (USD Million)
42. Germany Alopecia Market, By Disease Type, 2018-2030 (USD Million)
43. Germany Alopecia Market, By Gender, 2018-2030 (USD Million)
44. Germany Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
45. Germany Alopecia Market, By End-use, 2018-2030 (USD Million)
46. France Alopecia Market, By Treatment, 2018-2030 (USD Million)
47. France Alopecia Market, By Disease Type, 2018-2030 (USD Million)
48. France Alopecia Market, By Gender, 2018-2030 (USD Million)
49. France Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
50. France Alopecia Market, By End-use, 2018-2030 (USD Million)
51. Spain Alopecia Market, By Treatment, 2018-2030 (USD Million)
52. Spain Alopecia Market, By Disease Type, 2018-2030 (USD Million)
53. Spain Alopecia Market, By Gender, 2018-2030 (USD Million)
54. Spain Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
55. Spain Alopecia Market, By End-use, 2018-2030 (USD Million)
56. Italy Alopecia Market, By Treatment, 2018-2030 (USD Million)
57. Italy Alopecia Market, By Disease Type, 2018-2030 (USD Million)
58. Italy Alopecia Market, By Gender, 2018-2030 (USD Million)
59. Italy Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
60. Italy Alopecia Market, By End-use, 2018-2030 (USD Million)
61. Denmark Alopecia Market, By Treatment, 2018-2030 (USD Million)
62. Denmark Alopecia Market, By Disease Type, 2018-2030 (USD Million)
63. Denmark Alopecia Market, By Gender, 2018-2030 (USD Million)
64. Denmark Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
65. Denmark Alopecia Market, By End-use, 2018-2030 (USD Million)
66. Sweden Alopecia Market, By Treatment, 2018-2030 (USD Million)
67. Sweden Alopecia Market, By Disease Type, 2018-2030 (USD Million)
68. Sweden Alopecia Market, By Gender, 2018-2030 (USD Million)
69. Sweden Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
70. Sweden Alopecia Market, By End-use, 2018-2030 (USD Million)
71. Norway Alopecia Market, By Treatment, 2018-2030 (USD Million)
72. Norway Alopecia Market, By Disease Type, 2018-2030 (USD Million)
73. Norway Alopecia Market, By Gender, 2018-2030 (USD Million)
74. Norway Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
75. Norway Alopecia Market, By End-use, 2018-2030 (USD Million)
76. Asia Pacific Alopecia Market, By Country, 2018-2030 (USD Million)
77. Asia Pacific Alopecia Market, By Treatment, 2018-2030 (USD Million)
78. Asia Pacific Alopecia Market, By Disease Type, 2018-2030 (USD Million)
79. Asia Pacific Alopecia Market, By Gender, 2018-2030 (USD Million)
80. Asia Pacific Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
81. Asia Pacific Alopecia Market, By End-use, 2018-2030 (USD Million)
82. Japan Alopecia Market, By Treatment, 2018-2030 (USD Million)
83. Japan Alopecia Market, By Disease Type 2018-2030 (USD Million)
84. Japan Alopecia Market, By Gender, 2018-2030 (USD Million)
85. Japan Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
86. Japan Alopecia Market, By End-use, 2018-2030 (USD Million)
87. China Alopecia Market, By Treatment, 2018-2030 (USD Million)
88. China Alopecia Market, By Disease Type, 2018-2030 (USD Million)
89. China Alopecia Market, By Gender, 2018-2030 (USD Million)
90. China Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
91. China Alopecia Market, By End-use, 2018-2030 (USD Million)
92. India Alopecia Market, By Treatment, 2018-2030 (USD Million)
93. India Alopecia Market, By Disease Type, 2018-2030 (USD Million)
94. India Alopecia Market, By Gender, 2018-2030 (USD Million)
95. India Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
96. India Alopecia Market, By End-use, 2018-2030 (USD Million)
97. South Korea Alopecia Market, By Treatment 2018-2030 (USD Million)
98. South Korea Alopecia Market, By Disease Type, 2018-2030 (USD Million)
99. South Korea Alopecia Market, By Gender, 2018-2030 (USD Million)
100. South Korea Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
101. South Korea Alopecia Market, By End-use, 2018-2030 (USD Million)
102. Australia Alopecia Market, By Treatment 2018-2030 (USD Million)
103. Australia Alopecia Market, By Disease Type, 2018-2030 (USD Million)
104. Australia Alopecia Market, By Gender, 2018-2030 (USD Million)
105. Australia Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
106. Australia Alopecia Market, By End-use, 2018-2030 (USD Million)
107. Thailand Alopecia Market, By Treatment 2018-2030 (USD Million)
108. Thailand Alopecia Market, By Disease Type, 2018-2030 (USD Million)
109. Thailand Alopecia Market, By Gender, 2018-2030 (USD Million)
110. Thailand Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
111. Thailand Alopecia Market, By End-use, 2018-2030 (USD Million)
112. Latin America Alopecia Market, By Country, 2018-2030 (USD Million)
113. Latin America Alopecia Market, By Treatment, 2018-2030 (USD Million)
114. Latin America Alopecia Market, By Disease Type, 2018-2030 (USD Million)
115. Latin America Alopecia Market, By Gender, 2018-2030 (USD Million)
116. Latin America Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
117. Latin America Alopecia Market, By End-use, 2018-2030 (USD Million)
118. Brazil Alopecia Market, By Treatment, 2018-2030 (USD Million)
119. Brazil Alopecia Market, By Disease Type 2018-2030 (USD Million)
120. Brazil Alopecia Market, By Gender, 2018-2030 (USD Million)
121. Brazil Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
122. Brazil Alopecia Market, By End-use, 2018-2030 (USD Million)
123. Mexico Alopecia Market, By Treatment, 2018-2030 (USD Million)
124. Mexico Alopecia Market, By Disease Type, 2018-2030 (USD Million)
125. Mexico Alopecia Market, By Gender, 2018-2030 (USD Million)
126. Mexico Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
127. Mexico Alopecia Market, By End-use, 2018-2030 (USD Million)
128. Argentina Alopecia Market, By Treatment 2018-2030 (USD Million)
129. Argentina Alopecia Market, By Disease Type, 2018-2030 (USD Million)
130. Argentina Alopecia Market, By Gender, 2018-2030 (USD Million)
131. Argentina Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
132. Argentina Alopecia Market, By End-use, 2018-2030 (USD Million)
133. Middle East & Africa Alopecia Market, By Country, 2018-2030 (USD Million)
134. Middle East & Africa Alopecia Market, By Treatment, 2018-2030 (USD Million)
135. Middle East & Africa Alopecia Market, By Disease Type, 2018-2030 (USD Million)
136. Middle East & Africa Alopecia Market, By Gender, 2018-2030 (USD Million)
137. Middle East & Africa Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
138. Middle East & Africa Alopecia Market, By End-use, 2018-2030 (USD Million)
139. South Africa Alopecia Market, By Treatment, 2018-2030 (USD Million)
140. South Africa Alopecia Market, By Disease Type, 2018-2030 (USD Million)
141. South Africa Alopecia Market, By Gender, 2018-2030 (USD Million)
142. South Africa Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
143. South Africa Alopecia Market, By End-use, 2018-2030 (USD Million)
144. Saudi Arabia Alopecia Market, By Treatment, 2018-2030 (USD Million)
145. Saudi Arabia Alopecia Market, By Disease Type, 2018-2030 (USD Million)
146. Saudi Arabia Alopecia Market, By Gender, 2018-2030 (USD Million)
147. Saudi Arabia Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
148. Saudi Arabia Alopecia Market, By End-use, 2018-2030 (USD Million)
149. UAE Alopecia Market, By Treatment, 2018-2030 (USD Million)
150. UAE Alopecia Market, By Disease Type, 2018-2030 (USD Million)
151. UAE Alopecia Market, By Gender, 2018-2030 (USD Million)
152. UAE Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
153. UAE Alopecia Market, By End-use, 2018-2030 (USD Million)
154. Kuwait Alopecia Market, By Treatment 2018-2030 (USD Million)
155. Kuwait Alopecia Market, By Disease Type, 2018-2030 (USD Million)
156. Kuwait Alopecia Market, By Gender, 2018-2030 (USD Million)
157. Kuwait Alopecia Market, By Sales Channel, 2018-2030 (USD Million)
158. Kuwait Alopecia Market, By End-use, 2018-2030 (USD Million)
159. Company Overview
160. Financial Performance
161. Product Benchmarking
162. Strategic Initiatives
List of Figures
1. Alopecia market segmentation
2. Market research process
3. Information procurement
4. Primary research pattern
5. Market research approaches
6. Value-chain-based sizing & forecasting
7. QFD modeling for market share assessment
8. Market formulation & validation
9. Market outlook (2022)
10. Penetration & growth prospect mapping
11. Market driver relevance analysis (Current & future impact)
12. Prevalence of PCOS, by WHO regions
13. Incidence of cancer, by WHO regions
14. Prevalence of rheumatoid arthritis, by WHO regions
15. Market restraint relevance analysis (Current & future impact)
16. Porter’s five forces analysis
17. SWOT analysis, by factor (political & legal, economic, and technological)
18. Clinical trials for alopecia areata and androgenic alopecia
19. Global Alopecia market: disease type: Key takeaways
20. Global Alopecia market: Disease type movement analysis
21. Global Alopecia areata market, 2018-2030 (USD Million)
22. Global Male alopecia areata market, 2018-2030 (USD Million)
23. Global Female alopecia areata market, 2018-2030 (USD Million)
24. Global Cicatricial alopecia market, 2018-2030 (USD Million)
25. Global Male cicatricial alopecia market, 2018-2030 (USD Million)
26. Global Female cicatricial alopecia market, 2018-2030 (USD Million)
27. Global Traction alopecia market, 2018-2030 (USD Million)
28. Global Male traction alopecia market, 2018-2030 (USD Million)
29. Global Female traction alopecia market, 2018-2030 (USD Million)
30. Global Alopecia totalis market, 2018-2030 (USD Million)
31. Global Male alopecia totalis market, 2018-2030 (USD Million)
32. Global Female alopecia totalis market, 2018-2030 (USD Million)
33. Global Alopecia universalis market, 2018-2030 (USD Million)
34. Global Male alopecia universalis market, 2018-2030 (USD Million)
35. Global Female alopecia universalis market, 2018-2030 (USD Million)
36. Global Androgenetic alopecia market, 2018-2030 (USD Million)
37. Global Male androgenetic alopecia market, 2018-2030 (USD Million)
38. Global Female androgenetic alopecia market, 2018-2030 (USD Million)
39. Global Other alopecia market, 2018-2030 (USD Million)
40. Global Male other alopecia market, 2018-2030 (USD Million)
41. Global Female other alopecia market, 2018-2030 (USD Million)
42. Global Alopecia market treatment outlook: Key takeaways
43. Global Alopecia market: Treatment movement analysis
44. Global Pharmaceuticals market, 2018-2030 (USD Million)
46. Global Topical Pharmaceuticals market, 2018-2030 (USD Million)
46. Global Topical OTC Pharmaceuticals market, 2018-2030 (USD Million)
47. Global Topical OTC Minoxidil market, 2018-2030 (USD Million)
48. Global Topical OTC Others market, 2018-2030 (USD Million)
49. Global Topical Prescription Pharmaceuticals market, 2018-2030 (USD Million)
50. Global Topical Prescription Betamethasone Dipropionate market, 2018-2030 (USD Million)
51. Global Topical Prescription Fluocinolone Acetonide market, 2018-2030 (USD Million)
52. Global Topical Prescription Finasteride market, 2018-2030 (USD Million)
53. Global Topical Prescription Minoxidil market, 2018-2030 (USD Million)
54. Global Oral Pharmaceuticals market, 2018-2030 (USD Million)
55. Global Oral OTC Pharmaceuticals market, 2018-2030 (USD Million)
56. Global Oral Prescription Pharmaceuticals market, 2018-2030 (USD Million)
57. Global Oral Prescription Minoxidil market, 2018-2030 (USD Million)
58. Global Oral Prescription Finasteride market, 2018-2030 (USD Million)
59. Global Oral Prescription Corticosteroids market, 2018-2030 (USD Million)
60. Global Oral Prescription Others (JAK inhibitors and others) market, 2018-2030 (USD Million)
61. Global PRP market, 2018-2030 (USD Million)
62. Global Devices market, 2018-2030 (USD Million)
63. Global Laser Cap market, 2018-2030 (USD Million)
64. Global Laser Comb market, 2018-2030 (USD Million)
65. Global Laser Helmet market, 2018-2030 (USD Million)
66. Global Alopecia market end-use outlook key takeaways
67. Global Alopecia market: End-use movement analysis
68. Global Dermatology clinic market, 2018-2030 (USD Million)
69. Global Homecare setting market, 2018-2030 (USD Million)
70. Global Alopecia market sales channel outlook key takeaways
71. Global Alopecia market: Sales channel movement analysis
72. Global Prescription market, 2018-2030 (USD Million)
73. Global OTC market, 2018-2030 (USD Million)
74. Global Alopecia market gender outlook key takeaways
75. Global Alopecia market: Gender movement analysis
76. Global Male alopecia market, 2018-2030 (USD Million)
77. Global Female alopecia market, 2018-2030 (USD Million)
78. Regional outlook, 2022 & 2030
79. Regional marketplace: Key takeaways
80. North America
81. North America alopecia market, 2018-2030 (USD Million)
82. U.S.
83. U.S. alopecia market, 2018-2030 (USD Million)
84. Canada
85. Canada alopecia market, 2018-2030 (USD Million)
86. Europe
87. Europe alopecia market, 2018-2030 (USD Million)
88. UK
89. UK alopecia market, 2018-2030 (USD Million)
90. Germany
91. Germany alopecia market, 2018-2030 (USD Million)
92. Spain
93. Spain alopecia market, 2018-2030 (USD Million)
94. France
95. France alopecia market, 2018-2030 (USD Million)
96. Italy
97. Italy alopecia market, 2018-2030 (USD Million)
98. Denmark
99. Denmark alopecia market, 2018-2030 (USD Million)
100. Sweden
101. Sweden alopecia market, 2018-2030 (USD Million)
102. Norway
103. Norway alopecia market, 2018-2030 (USD Million)
104. Asia Pacific
105. Asia Pacific alopecia market, 2018-2030 (USD Million)
106. Japan
107. Japan alopecia market, 2018-2030 (USD Million)
108. China
109. China alopecia market, 2018-2030 (USD Million)
110. India
111. India alopecia market, 2018-2030 (USD Million)
112. South Korea
113. South Korea alopecia market, 2018-2030 (USD Million)
114. Australia
115. Australia alopecia market, 2018-2030 (USD Million)
116. Thailand
117. Thailand alopecia market, 2018-2030 (USD Million)
118. Latin America
119. Latin America alopecia market, 2018-2030 (USD Million)
120. Brazil
121. Brazil alopecia market, 2018-2030 (USD Million)
122. Mexico
123. Mexico alopecia market, 2018-2030 (USD Million)
124. Argentina
125. Argentina alopecia market, 2018-2030 (USD Million)
126. Middle East and Africa
127. MEA alopecia market, 2018-2030 (USD Million)
128. South Africa
129. South Africa alopecia market, 2018-2030 (USD Million)
130. Saudi Arabia
131. Saudi Arabia alopecia market, 2018-2030 (USD Million)
132. UAE
133. UAE alopecia market, 2018-2030 (USD Million)
134. Kuwait
135. Kuwait alopecia market, 2018-2030 (USD Million)

Companies Mentioned

  • Janssen Global Services Inc.
  • Cipla Limited
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sun Pharmaceuticals Industries Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Aurobindo Pharma
  • Viatris Inc.
  • Pfizer, Inc.
  • Lilly
  • Lexington Intl., LLC (Devices)
  • Freedom Laser Therapy (iRestore ID-520 helmet)
  • Curallux, LLC.
  • Apira Science Inc. (iGROW Laser)
  • Revian Inc.
  • Theradome
  • Lutronic

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2023-2030 - Product Image

Global Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Forecast 2023-2030

  • Report
  • 184 Pages
  • Global
From
Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2023-2030 - Product Image

Global Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Forecast 2023-2030

  • Report
  • 186 Pages
  • Global
From
Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Image

Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • 134 Pages
  • Global
From
Global Alopecia Market Report and Forecast 2023-2031 - Product Image

Global Alopecia Market Report and Forecast 2023-2031

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.